in conclusion , epirubicin is a new antitumor agent having an antitumor effect similar or superior to that of doxorubicin with the various toxicities , including cardiotoxicity , which are reduced in this drug in comparison to those of doxorubicin .
C0014582
epirubicin
C0013089
doxorubicin